Granulomatous meningoencephalomyelitis in dogs: A review

Emma J O'Neill1, Darren Merrett, Boyd Jones

  • 1Department of Small Animal Clinical Studies, Faculty of Veterinary Medicine, University College Dublin, Ireland. emma.oneill@ucd.ie.

Irish Veterinary Journal
|August 20, 2011
PubMed

Insights

Granulomatous meningoencephalomyelitis (GME) is an inflammatory central nervous system disease in dogs. This review covers its clinical signs, pathology, suspected immune-mediated cause, and current treatment strategies for canine GME.

Area of Science:

  • Veterinary Neurology
  • Immunology
  • Canine Pathology

Background:

  • Granulomatous meningoencephalomyelitis (GME) is a serious inflammatory condition affecting the canine central nervous system.
  • Characterized by specific lesions in the brain and spinal cord, GME presents diagnostic challenges due to its unknown etiology.
  • A suspected immune-mediated mechanism underlies GME, prompting further investigation into its pathogenesis.

Purpose of the Study:

  • To provide a comprehensive review of Granulomatous meningoencephalomyelitis (GME) in dogs.
  • To discuss the typical clinical presentation, pathological findings, and suspected causes of canine GME.
  • To outline current diagnostic considerations and therapeutic approaches for GME.

Main Methods:

  • Literature review of existing studies on canine Granulomatous meningoencephalomyelitis (GME).
  • Analysis of typical clinical history and neurological signs associated with GME.
  • Examination of pathological characteristics, including CNS lesions and inflammatory patterns.
  • Discussion of differential diagnoses and current treatment modalities for GME.

Main Results:

  • GME presents with focal or disseminated granulomatous lesions, non-suppurative meningitis, and perivascular cuffing in the canine CNS.
  • The precise cause of GME remains undetermined, but evidence suggests an immune-mediated origin.
  • A range of clinical signs and pathological findings are typical for GME, aiding in its identification.

Conclusions:

  • Understanding the clinical and pathological features of GME is crucial for accurate diagnosis in dogs.
  • While the etiology is likely immune-mediated, further research is needed to elucidate the exact pathogenesis of GME.
  • Current treatment strategies for canine GME focus on managing inflammation and immune modulation, with variable outcomes.

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...